iSpecimen

Matches life-science researchers with annotated human biofluids, solid tissue, and hematopoietic stem and immune cells through an order-driven procurement marketplace. Customers pay per specimen or project, while supplying healthcare organizations and commercial providers receive a share of revenue. The offer spans remnant and consented research-use-only samples, banked inventory, prospective custom collections, clinical annotation, and matched sets.

Rather than maintaining a large proprietary biobank, the company harmonizes de-identified records from provider systems and coordinates cohort search, contracting, compliance, ordering, fulfillment, and supplier revenue sharing. Its network extends across the Americas, Europe, and Asia, but customer demand is centered in the Americas and fulfillment depends on suppliers meeting precise specimen criteria.

Operations rely on privacy, human-subject, consent, shipping, import/export, and cross-border data-transfer requirements. The marketplace migration remains incomplete: some product lines still lack full self-service patient-level search and pricing functionality.